B+
Bull case
25%
Probability
Target price
$31.67
Analysis reference price unavailable
Analysis 2026-09-13 · RankAlpha Sentiment Codex
PRVA
Privia Health GroupANasdaq / Health Care Equipment & Services
Last Price
Quote time unavailable
AI scenario view
RankAlpha Sentiment CodexMost likely
B
Base case
50%
Probability
Target price
$24.50
Analysis reference price unavailable
Analysis 2026-09-13 · RankAlpha Sentiment Codex
B-
Bear case
25%
Probability
Target price
$16.50
Analysis reference price unavailable
Analysis 2026-09-13 · RankAlpha Sentiment Codex
The current persistence contract does not provide an exact AI reference price. RankAlpha therefore does not calculate scenario return from the live quote. How scenarios are presented
AI sentiment snapshot
Latest data as of 2026-09-13
Recent news sentiment (30D)
+0.7
Mixed
Company
-
Unavailable
Macro
-
Unavailable
Pulse
-
Unavailable
Weekly research (10D)
+30.0
Positive
Sentiment proxy
+86.9
Score
AI commentary
Available headlines emphasize strong Q2 growth and raised guidance, but the evidence packet lacks sufficient social coverage, options skew, short-interest data, and confirmed post-print analyst revisions. The primary earnings exhibit supports a positive directional prior, while limited valuation and peer evidence favors a cautious monitoring stance.
RankAlpha Sentiment Codex - 2026-09-13
Open full AI memoEvidence flagged
No evidence quality warning is currently attached to this memo.
Impact
standard
Confidence
-
AI events
2026-12-31eventExecution against raised FY2026 guidanceHigh impact
Privia raised full-year 2026 guidance across key financial metrics after Q2 revenue increased 21.4%, adjusted EBITDA increased 29.1%, and net income reached $9.0 million. Continued delivery against the updated ranges would reinforce the earnings thesis [#SEC-8K-2026-08-06].
2026-12-31catalystInsider-sale sentiment overhangHigh impact
July Form 4 filings reported open-market sales by the CFO and a director, including director sales following option exercises. These transactions may weigh on near-term sentiment, although they do not establish operating deterioration [#SEC-FORM4-2026-07-07].
2027-12-31catalystProvider and value-based-care network scalingHigh impact
Implemented providers increased 10.1% year over year to 5,644 and attributed lives increased 19.2% to 1.647 million, accompanied by 20.1% platform-contribution growth. Sustaining that operating leverage could support a longer-term rerating [#SEC-8K-2026-08-06].
Recommendation
N/A
No formal recommendation provided.
As of 2026-09-13 • Updated nightlySource: Internal modelMethodology